We recently released a list According to billionaires, 10 best new stocks can be purchased. In this article, we will explore where Solventum Corporation (NYSE:SOLV) conflicts with other best new stocks.
International IPO activities in the first quarter of 2025 are characterized by geopolitical shifts and serious uncertainty arising from changing tariff policies around the world. According to EY Global's April 10, 2025 report, the global IPO market remained stable in terms of quantity, but value grew by 20%. There were 291 IPOs in the first quarter of 2025, with a total value of US$29.3 billion. It is worth noting that the United States is the key player as it released its third Q1 performance, with a total of 59 lists. On the other hand, the Asia-Pacific market also showed signs of recovery, while the European Elderly region remained stable year-on-year.
The current global macroeconomic environment brings challenges and opportunities to global IPOs. For example, tariff policies and ongoing trade wars have raised inflation expectations and created uncertainty about monetary policy. On the other hand, geopolitical tensions have led to increased global budget spending, resulting in a surge in investment from the Department of Aerospace and Defense. EY Global's report expects a surge in IPO activity in the segment. In addition, the disruptive trends in artificial intelligence allow IPO candidates to use the technology to enhance their market strategies and products. According to the report, AI technology has begun to become an integral part of companies that operate in the financial, health and life sciences industries.
Although the number of IPOs in the U.S. market has increased by 51% compared to 2024, the future seems uncertain. George Chan, head of EY Global IPO, stressed that the growth in IPO activity in the first quarter is amid the optimistic market outlook at the beginning of the year. However, many companies planning to plan their IPOs in the first or second quarter of this year have delayed their public offerings until later or 2026. Chan suggests that it is important for investors to find companies with unshakable fundamentals, agility and adaptability to make the market uncertain.
To curate the 10 best new stock lists based on billionaires, we used Finviz Stock Filter and Insider Monkey’s Q4 2024 Billionaire Database. Using filters, we summarize a list of companies that have been published in the past two years. After sorting the list by market value, we rank each stock in the order of rising number of billionaires investors. We also added hedge fund sentiment around each stock. Please note that the data was recorded on April 25, 2025. Also, note that if two or more stocks have an equal number of billionaire investors, we use market cap as a hitter.
Why are we interested in stocks that hedge funds to accumulate? The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our strategy for quarterly newsletters selects 14 small and large stocks every quarter, returning 373.4% since May 2014, beating its benchmark by 218 percentage points (See more details here).
A health care provider performs an MRI scan on patients with brain injuries.
Market value: US$11.683 billion
Number of hedge fund holders: 41
Number of billionaires: 12
Total value held by billionaires: $784,436,827
Solventum Corporation (NYSE:SOLV) is an international healthcare company that develops and sells a range of products and solutions for the medical sector. The company operates through four major business areas including medical surgery, dental solutions, health information systems, and purification and filtration. The company left from 3 million in 2024 and now has a deal as an independent company.
Solventum Corporation (NYSE:SOLV) is being completely independent of its derivatives. Since March, the company has withdrawn from about a quarter of more than 200 transitional service agreements. It also implemented a new ERP system, the Enterprise Resource Planning System, in six countries. Management notes that it plans to complete some large ERP implementations currently and next year.
During this transition period, Solventum Corporation (NYSE:SOLV) is still releasing growth. In the fourth fiscal year of 2024, the company's sales rose 2.3% to $2.1 billion. This growth is driven by outstanding performance in the Medsurg space, which contributed $1.2 billion in sales. Going forward, management is expected to increase sales by 1% to 2%. According to the billionaire, it is one of the best new shares to buy.
The Diamond Hill Mid Cap policy lists the following content about Solventum Corporation (NYSE:SOLV) in it Q4 2024 Investor Letter:
“As values have continued rising and the economic cycle has gotten relatively long in the tooth, we've thought carefully about where and how we are exposed to more cyclical stocks. As such, we initiated a number of new positions in Q4, including ICON, Informatica, Teledyne Technologies, LPL Financial Holdings, Teleflex Incorporated and Solventum Corporation (NYSE:SOLV).
Overall, solvents Ranked fourth According to billionaires, among the best new stocks we buy. While we acknowledge the potential for SOLV to grow, our belief is that AI stocks offer higher returns in a shorter time frame and offer greater hope in this. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for AI stocks that are more promising than SOLV but have less than 5 times its earnings, check out our report Cheapest AI stocks.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks.
Disclosure: None. This article was originally published in Inside monkey.